• Title/Summary/Keyword: Barrier Options

Search Result 40, Processing Time 0.023 seconds

Mucopolysaccharidosis Type III: Overview and Future Therapeutic Approaches

  • Kwak, Min Jung
    • Journal of mucopolysaccharidosis and rare diseases
    • /
    • v.3 no.1
    • /
    • pp.1-8
    • /
    • 2017
  • Mucopolysaccharidosis (MPS) type III, or Sanfilippo syndrome is a rare autosomal recessive lysosomal storage disorder. It is caused by a deficiency of one of four enzymes involved in the degradation of the glycosaminoglycan (GAG) heparan sulfate. The resultant cellular accumulation of heparan sulfate causes various clinical manifestations. MPS III is divided into four subtypes depending on the deficient enzyme: MPS IIIA, MPS IIIB, MPS IIIC and MPS IIID. All the subtypes show similar clinical features and are characterized by progressive degeneration of the central nervous system (CNS). Main purpose of the treatment for MPS III is to prevent neurologic deterioration. However, conventional enzyme replacement therapy has a limitation due to inability to cross the blood-brain barrier. Several experimental treatment options for MPS III are being developed.

Site Mitigation Plan for Noise Sources from Construction Sites by Developing Movable Noise Barriers (건설공사장 이동식 방음시설물의 음향특성)

  • Lee, Sung Chan;Chung, Jin Yun;Im, Jung Bin
    • Transactions of the Korean Society for Noise and Vibration Engineering
    • /
    • v.25 no.1
    • /
    • pp.58-64
    • /
    • 2015
  • There are a lot of different types of noise from construction site and it depends on construction stage, equipment type and number of operating equipments. The problem is that the almost noise from construction site is high level and some kinds of noise levels are over 100 dB. In addition, if construction site is located in downtown, there are a few options to reduce noise level. Therefore several site mitigation plans were developed to reduce different types of construction noises such as breaker work, gang form and asphalt saw. They were applied in site and evaluated noise reduction performance. The test result of site insertion loss was between 4~8 dB depends on the equipment and type of work.

Pricing Path-Dependent Equity-Indexed Annuities

  • Lee, Hang-Suck
    • Proceedings of the Korean Statistical Society Conference
    • /
    • 2002.11a
    • /
    • pp.191-196
    • /
    • 2002
  • Sales of equity-indexed annuities (EIAs) have rapidly increased, but the growth rates in sales have recently shown signs of slowing down because the current volatile equity market increases the costs of guarantees in EIAs. New EIAs need to be designed that are similar to existing EIAs but have a cheaper guarantee and a higher participation rate. This paper proposes three types of EIAs with higher participation rates: up-and-in barrier EIA, aulual reset EIA with up-and-in barriers, and partial-time lookbackEIA. It also presents a probability distribution and the method of Esscher transforms, with which explicit pricing formulas for these EIAs are derived.

  • PDF

Innovative Therapeutic Approaches for Mucopolysaccharidosis III

  • Sohn, Young Bae
    • Journal of mucopolysaccharidosis and rare diseases
    • /
    • v.4 no.2
    • /
    • pp.37-41
    • /
    • 2018
  • Mucopolysaccharidosis III (MPS III, Sanfilippo syndrome) is a rare autosomal recessive disease caused by a deficiency of one of four enzymes involved in the degradation of glycosaminoglycan (GAG). The resultant cellular accumulation of GAG causes various clinical manifestations. MPS III is divided into four subtypes depending on the deficient enzyme. All the subtypes show similar clinical features and are characterized by progressive degeneration of the central nervous system. A number of genetic and biochemical diagnostic methods have been developed. However, there is no effective therapy available for any form of MPS III, with treatment currently limited to clinical management of neurological symptoms. Main purpose of the treatment for MPS III is to prevent neurologic deterioration. Because conventional intravenous enzyme replacement therapy (ERT) has a limitation due to inability to cross the blood-brain barrier, several innovative therapeutic approaches for MPS III are being developed. This review covers the currently developing new therapeutic options for MPS III including high dose ERT, substrate reduction therapy, intrathecal or intraventricular ERT, fusion protein delivery using bioengineering technology, and gene therapy.

Temporomandibular joint re-ankylosis: a case report and literature review

  • Flora Kalita;Arunkumar KV
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • v.49 no.4
    • /
    • pp.218-222
    • /
    • 2023
  • Re-ankylosis is a common postoperative complication of temporomandibular joint (TMJ) ankylosis surgery. Various surgical options to prevent re-ankylosis, both with and without interpositional material, have been discussed in the literature. However, no standardized protocol has been suggested for management or prevention of TMJ ankylosis. This paper discusses the probable causes behind TMJ re-ankylosis and presents a case of unilateral TMJ re-ankylosis, which was managed by gap arthroplasty using an autologous abdominal dermal fat graft as an interpositional material and closely monitored for signs of relapse. Autologous fat graft acted as an effective barrier between the glenoid fossa and mandibular condyle, thus preventing dead space, hematoma and heterotrophic bone formation. A brief review of the literature and update on TMJ re-ankylosis are also presented.

Neuromodulation for Atrial Fibrillation Control

  • Seil Oh
    • Korean Circulation Journal
    • /
    • v.54 no.5
    • /
    • pp.223-232
    • /
    • 2024
  • Trigger and functional substrate are related to the tone of autonomic nervous system, and the role of the autonomic nerve is more significant in paroxysmal atrial fibrillation (AF) compared to non-paroxysmal AF. We have several options for neuromodulation to help to manage patients with AF. Neuromodulation targets can be divided into efferent and afferent pathways. On the efferent side, block would be an intuitive approach. However, permanent block is hard to achieve due to completeness of the procedure and reinnervation issues. Temporary block such as botulinum toxin injection into ganglionated plexi would be a possible option for post-cardiac surgery AF. Low-level subthreshold stimulation could also prevent AF, but the invasiveness of the procedure is the barrier for the general use. On the afferent side, block is also an option. Various renal denervation approaches are currently under investigation. Auditory vagus nerve stimulation is one of the representative low-level afferent stimulation methods. This technique is noninvasive and easy to apply, so it has the potential to be widely utilized if its efficacy is confirmed.

Application of Exosome for Diagnosis and Treatment of Diseases in the Central Nervous System (중추신경계 질환의 진단과 치료를 위한 엑소좀의 활용)

  • Jia Bak;Yun-Sik Choi
    • Journal of Life Science
    • /
    • v.33 no.9
    • /
    • pp.754-765
    • /
    • 2023
  • Exosomes are a type of extracellular vesicle containing proteins and messenger and microRNAs; they are secreted by all cell types. Once released, exosomes are selectively taken up by other cells adjacent or at a distance, releasing their contents and reprogramming the target cells. Since exosomes are natural vesicles produced by cells as small sizes, it is generally accepted that exosomes have a non-toxic nature and non-immunogenic behaviors. Recently, exosomes have elicited scientific attention as drug delivery vehicles to the central nervous system. The central nervous system has a blood-brain barrier that makes it difficult for drugs to penetrate. Thus, the blood-brain barrier has been a major obstacle to the development of drugs for treating neurodegenerative diseases. However, accumulating evidence suggests that exosomes can cross the blood-brain barrier primarily through transcytosis. Consequently, exosomes are expected to become a new delivery vehicle that can cross the blood-brain barrier and deliver drugs into the brain parenchyma. In addition, since different types of exosomes are secreted depending on the cell type and disease state, exosomes can also be utilized as biomarkers for the diagnosis of diseases in the central nervous system. In this review, we summarized recent research trends on exosomes, including clinical trials as biomarkers and treatment options for diseases in the central nervous system.

Hazard Prevention Using Multi-Level Debris Flow Barriers (다단식(多段式) 유연성 토석류 방지시설에 관한 적용성 검토 연구)

  • Baek, Yong;Choi, Youngchul;Kwon, Oil;Choi, Seungil
    • Journal of the Korean GEO-environmental Society
    • /
    • v.11 no.8
    • /
    • pp.15-23
    • /
    • 2010
  • Debris flows are a natural hazard which looks like a combination of flood, land and rock slide. Large rainfall in July 2006 produced several large scale debris flows and many small debris flows that resulted in loss of life and considerable property and railway damage, as was widely reported in the national media. The hazard "debris flow" is still insufficiently researched. Furthermore debris flows are very hard to predict. Flexible Ring net barriers are multi-functional mitigation devices commonly applied to rock fall or floating wood protection in floods, snow avalanches and also mud flows or granular debris flows, if properly dimensioned for the process or processes for which they are intended. Overtopping of the barriers by debris flows and sediment transport is possible, supporting the design concept that a series of barriers may be used to stop volumes of debris larger than are possible using only one barrier. The future for these barrier concepts looks promising because these barriers represent the state of art for such applications and are superior to many other available options.

Acellular Dermal Matrix to Treat Full Thickness Skin Defects: Follow-Up Subjective and Objective Skin Quality Assessments

  • Park, Jae Yeon;Lee, Tae Geun;Kim, Ji Ye;Lee, Myung Chul;Chung, Yoon Kyu;Lee, Won Jai
    • Archives of Craniofacial Surgery
    • /
    • v.15 no.1
    • /
    • pp.14-21
    • /
    • 2014
  • Background: There are several options for replacement of the dermal layer in fullthickness skin defects. In this study, we present the surgical outcomes of reconstruction using acellular dermal substitutes by means of objective and subjective scar assessment tools. Methods: We retrospectively reviewed the medical records of 78 patients who had undergone autologous split-thickness skin graft with or without concomitant acellular dermal matrix (CGDerm or AlloDerm) graft. We examined graft survival rate and evaluated postoperative functional skin values. Individual comparisons were performed between the area of skin graft and the surrounding normal skin. Nine months after surgery, we compared the skin qualities of CGDerm graft group (n=25), AlloDerm graft group (n=8) with skin graft only group (n=23) each other using the objective and subjective measurements. Results: The average of graft survival rate was 93% for CGDerm group, 92% for AlloDerm group and 86% for skin graft only group. Comparing CGDerm grafted skin to the surrounding normal skin, mean elasticity, hydration, and skin barrier values were 87%, 86%, and 82%, respectively. AlloDerm grafted skin values were 84%, 85%, and 84%, respectively. There were no statistical differences between the CGDerm and AlloDerm groups with regard to graft survival rate and skin functional analysis values. However, both groups showed more improvement of skin quality than skin graft only group. Conclusion: The new dermal substitute (CGDerm) demonstrated comparable results with regard to elasticity, humidification, and skin barrier effect when compared with conventional dermal substitute (AlloDerm).

Diagnosis and Clinical Management of Retrograde Peri-Implantitis Associated with Adjacent Apical Periodontitis: a Case Report

  • Lee, Kwan-Joo;Song, Young Woo;Jung, Ui-Won;Cha, Jae-Kook
    • The Journal of the Korean dental association
    • /
    • v.58 no.6
    • /
    • pp.336-345
    • /
    • 2020
  • Peri-apical implant lesion, also known as 'retrograde peri-implantitis' can occur with multifactorial etiological factors. The purpose of this case report is to demonstrate resolution of periapical implant lesion by removal of causative factors and saving implant by regenerative therapy. A 54-year old male patient with mild dull pain around implant on the right mandibular second premolar area due to persistent peri-apical infection of the adjacent first premolar was treated. Extraction of tooth with symptomatic apical periodontitis and regenerative therapy on the buccal fenestration area of the implant and extraction site were performed. After 6-month reentry, notable regenerated bone tissue around implant was found, and implant placement on the previous extraction site was performed. After 14-month follow-up from the regenerative therapy, neither biological nor mechanical complication could be found around the implant, evidenced by high implant stability, normal clinical probing depth, and absence of discomfort spontaneously and during masticatory function. In conclusion, surgical intervention including regenerative therapy using bone graft and barrier membrane on periapical implant lesion can be suggested as one of the treatment options considering the extent of periapical lesion.

  • PDF